A 1-Month, Prospective, Multicenter, Randomized, Dose-Ranging, Sham-Controlled, Blinded Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects

Trial Profile

A 1-Month, Prospective, Multicenter, Randomized, Dose-Ranging, Sham-Controlled, Blinded Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Otitis media
  • Focus Adverse reactions
  • Sponsors Otonomy
  • Most Recent Events

    • 03 Aug 2017 According to an Otonomy media release, results from this study were presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
    • 12 May 2017 According to an Otonomy media release, data will be presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
    • 04 Oct 2016 According to an Otonomy media release, additional results from this trial will be presented at the Otonomy Investor and Analyst Day on October 7 and at an upcoming medical conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top